Sven Almer

Publications
Grants
Public outreach and news

Articles

Article: ORAL DISEASES. 2024
Salivary calprotectin and neutrophils in inflammatory bowel disease in relation to oral diseases
Majster M; Almer S; Malmqvist S; Johannsen A; Lira-Junior R; Bostroem EA
Article: JOURNAL OF CROHNS & COLITIS. 2024;18(3):349-359
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
Zheng T; Roda G; Zabana Y; Escudero-Hernandez C; Liu X; Chen Y; Camargo Tavares L; Bonfiglio F; Mellander M-R; Janczewska I; Vigren L; Sjoberg K; Ohlsson B; Almer S; Halfvarson J; Miehlke S; Madisch A; Lieb W; Kupcinskas J; Weersma RK; Bujanda L; Julia A; Marsal S; Esteve M; Guagnozzi D; Fernandez-Banares F; Ferrer C; Peter I; Ludvigsson JF; Pardi D; Verhaegh B; Jonkers D; Pierik M; Munch A; Franke A; Bresso F; Khalili H; Colombel J-F; D'Amato M
Journal article: JOURNAL OF CROHNS & COLITIS. 2024;18(Supplement_1):i2076
P1164 Early monitoring of ustekinumab concentration after induction is related to clinical remission in ulcerative colitis & Crohn`s disease - STOCUSTE study
Sabhan H; Johansson F; Bello F; Wennerström C; Forsberg O; Borin A; Almer S; Höög C; Söderman C; Lördal M
Journal article: JOURNAL OF CROHNS & COLITIS. 2024;18(Supplement_1):i1689-i1691
P929 Relation between Crohn’s disease phenotype and response to ustekinumab in Stockholm – the STOCUSTE study
Bello F; Muhsen S; Sabhan H; Borin A; Johansson F; Höög C; Forsberg O; Wennerström C; Söderman C; Lördal M; Almer S
Journal article: JOURNAL OF CROHNS & COLITIS. 2024;18(Supplement_1):i611
P256 Relationship and sexuality in Inflammatory Bowel Disease: results from a patient questionnaire
Jäghult S; Bello F; Almer S
Article: GASTRO HEP ADVANCES. 2024;3(5):618-633
Discerning Endoscopic Severity of Inflammatory Bowel Disease by Scoping the Peripheral Blood Transcriptome.
Söderman J; Almer S
Article: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2024;17:17562848241242700
Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study
Bello F; Muhsen S; Sabhan H; Borin A; Johansson F; Hoog C; Forsberg O; Wennerstrom C; Soderman C; Lordal M; Almer S
Journal article: GASTROENTEROLOGY. 2023;164(6):s-668-s-669
Su1758 A NOVEL SERUM PROTEIN SIGNATURE AS BIOMARKER FOR INFLAMMATORY BOWEL DISEASE: A DIAGNOSTIC PERFORMANCE AND PREDICTION MODELLING STUDY USING DATA FROM TWO INDEPENDENT INCEPTION COHORTS
Bazov I; Kruse R; Daniel B; Eriksson C; Hedin CR; Carlson M; van Nieuwenhoven M; Keita ÅV; Magnusson MK; Almer S; Strid H; Mathisen CB; Bengtson M-B; Aaabrekke TB; Medhus AW; Detlie TE; Frigstad SO; Huppertz-Hauss G; Opheim R; Ricanek P; Kristensen V; Salihovic S; D'Amato M; Ohman L; Söderholm JD; Lindqvist CM; Repsilber D; H⊘ivik ML; Halfvarson J
Article: COLORECTAL DISEASE. 2023;25(4):695-706
Development of a core descriptor set for Crohn's anal fistula
Lee MJ; Williams KM; Lamidi S; Coe PO; Bordeianou LG; Hart AL; Hind D; Lindsay JO; Lobo AJ; Myrelid P; Raine T; Sebastian S; Fearnhead NS; Lee MJ; Adams K; Almer S; Ananthakrishnan A; Bethune RM; Block M; Brown SR; Cirocco WC; Cooney R; Davies J; Atici SD; Dhar A; Din S; Drobne D; Espin-Basany E; Evans JP; Fleshner PR; Folkesson J; Fraser A; Graf W; Hahnloser D; Hager J; Hancock L; Hanzel J; Hargest R; Hedin CRH; Hill J; Ihle C; Jongen J; Kader R; Karmiris K; Katsanos KH; Keller DS; Kopylov U; Koutrabakis IE; Lamb CA; Landerholm K; Lee GC; Litta F; Limdi JK; Lopes EW; Madoff RD; Martin ST; Martin-Perez B; Michalopoulos G; Millan M; Munch A; Nakov R; Noor NM; Oresland T; Paquette IM; Pellino G; Perra T; Porcu A; Roslani AC; Samaan MA; Sebepos-Rogers GM; Segal JP; de Silva S; Soderholm M; Spinelli A; Speight A; Steinhagen RM; Stenstrom P; Tsimogiannis KE; Varma MG; Verma AM; Verstockt B; Warden C; Yassin N; Zawadzki A; Carr P; Devlin B; Mannick S; Avery P; Gecse KB; Goren I; Hellstrom PM; Kotze PG; McWhirter D; Naik AS; Sammour T; Selinger CP; Stein SL; Torres J; Wexner SD; Younge LC
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(6):5820
Differences in Whole-Blood Transcriptional Profiles in Inflammatory Bowel Disease Patients Responding to Vedolizumab Compared with Non-Responders
Haglund S; Soederman J; Almer S
Article: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2023;8(3):215-227
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
Louis E; Resche-Rigon M; Laharie D; Satsangi J; Ding N; Siegmund B; D'Haens G; Picon L; Bossuyt P; Vuitton L; Irving P; Viennot S; Lamb CA; Pollok R; Baert F; Nachury M; Fumery M; Gilletta C; Almer S; Ben-Horin S; Bouhnik Y; Colombel J-F; Hertervig E
Journal article: JOURNAL OF CROHNS & COLITIS. 2023;17(Supplement_1):i314-i315
P154 A novel serum protein signature as biomarker for Inflammatory Bowel Disease: A diagnostic performance and prediction modelling study using data from two independent inception cohorts
Bazov I; Kruse R; Bergemalm D; Eriksson C; Hedin CR; Carlson M; van Nieuwenhoven M; Keita ÅV; Magnusson MK; Almer S; Strid H; Mathisen CB-W; Bengtsson MB; Aabrekk TB; Medhus AW; Detlie TE; Frigstad SO; Huppertz-Hauss G; Opheim R; Ricanek P; Kristensen VA; Salihovic S; D'Amato M; Öhman L; Söderholm JD; Lindqvist CM; Repsilber D; Høivik ML; Halfvarson J; III S-IAI
Article: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2023;16:17562848231174953
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study
Visuri I; Eriksson C; Karlqvist S; Lykiardopoulos B; Karlen P; Grip O; Soderman C; Almer S; Hertervig E; Marsal J; Malmgren C; Delin J; Strid H; Sjoberg M; Bergemalm D; Hjortswang H; Halfvarson J
Article: JOURNAL OF CROHNS & COLITIS. 2022;16(7):1097-1109
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naive Inflammatory Bowel Disease
Juzenas S; Huebenthal M; Lindqvist CM; Kruse R; Steiert TA; Degenhardt F; Schulte D; Nikolaus S; Zeissig S; Bergemalm D; Almer S; Hjortswang H; Bresso F; Struening N; Kupcinskas J; Keller A; Lieb W; Rosenstiel P; Schreiber S; D'Amato M; Halfvarson J; Hemmrich-Stanisak G; Franke A
Article: NEJM EVID. 2022;1(8):evidoa2200061
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease.
Buhl S; Steenholdt C; Brynskov J; Christensen KR; Dorn-Rasmussen M; Thomsen OØ; Bendtzen K; Klausen TW; Dahlerup JF; Thorsgaard N; Jahnsen J; Molazahi A; Pedersen N; Kjeldsen J; Almer S; Dahl EE; Vind I; Cannon AG; Marsal J; Sipponen T; Agnholt JS; Kievit HAL; Aure SL; Martinsen L; Meisner S; Hansen JM; Ainsworth MA
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;23(13):6944
Inverse and Concordant Mucosal Pathway Gene Expressions in Inflamed and Non-Inflamed Ulcerative Colitis Patients: Potential Relevance to Aetiology and Pathogenesis
Soderman J; Berglind L; Almer S
Journal article: JOURNAL OF CROHNS & COLITIS. 2022;16(Supplement_1):i130-i131
DOP88 Long-term real-world data of ustekinumab in Crohn’s Disease – the Stockholm ustekinumab study – STOCUSTE
Bello F; Lördal M; Johansson F; Sabhan H; Muhsen S; Borin A; Forsberg O; Wennerström C; Söderman C; Almer S
Article: CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY. 2022;15:129-144
Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
Holst LM; Halfvarson J; Carlson M; Hedin C; Kruse R; Lindqvist CM; Bergemalm D; Almer S; Bresso F; Lundstrom ML; Repsilber D; D'Amato M; Keita A; Hjortswang H; Soderholm J; Sundin J; Tornblom H; Simren M; Strid H; Magnusson MK; Ohman L
Article: CELL RESEARCH. 2021;31(5):554-568
Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing
Mazzurana L; Czarnewski P; Jonsson V; Wigge L; Ringner M; Williams TC; Ravindran A; Bjorklund AK; Safholm J; Nilsson G; Dahlen S-E; Orre A-C; Al-Ameri M; Hoog C; Hedin C; Szczegielniak S; Almer S; Mjosberg J
Article: BMC GASTROENTEROLOGY. 2021;21(1):128
Whipple's disease: the great masquerader-a high level of suspicion is the key to diagnosis
Melas N; Amin R; Gyllemark P; Younes AH; Almer S
Article: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY. 2021;14:17562848211023386
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study
Eriksson C; Rundquist S; Lykiardopoulos V; Udumyan R; Karlen P; Grip O; Soderman C; Almer S; Hertervig E; Marsal J; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjoberg M; Oberg D; Bergemalm D; Hjortswang H; Halfvarson J
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(12):1411-1418
Rapid weight gain in infliximab treated Crohn's disease patients is sustained over time: real-life data over 12 months
Lepp J; Hoog C; Forsell A; Fyrhake U; Lordal M; Almer S
Article: INFLAMMATORY BOWEL DISEASES. 2020;26(10):1588-1596
Salivary and Serum Inflammatory Profiles Reflect Different Aspects of Inflammatory Bowel Disease Activity
Majster M; Lira-Junior R; Hoog CM; Almer S; Bostrom EA
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2020;18(10):2295-2304.e2
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
Hedin CRH; Sado G; Ndegwa N; Lytvyak E; Mason A; Montano-Loza A; Gerussi A; Saffi F; Thorburn D; Nilsson E; Larsson G; Moum BA; van Munster KN; Ponsioen CY; Levy C; Nogueira NF; Bowlus CL; Gotlieb N; Shibolet O; Lynch KD; Chapman RW; Rupp C; Vesterhus M; Jorgensen K; Rorsman F; Schramm C; Sabino J; Vermeire S; Zago A; Cazzagon N; Marschall H-U; Ytting H; Ben Belkacem K; Chazouilleres O; Almer S; Bergquist A
Journal article: GASTROENTEROLOGY. 2020;158(6):s-963
Mo1886 REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB IN CROHN'S DISEASE: WEEK 52 RESULTS FROM THE SWEDISH MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL SVEAH CD STUDY
Eriksson C; Rundquist S; Lykiardopoulos B; Udumyan R; Karlén P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjöberg M; Öberg D; Daniel B; Hjortswang H; Halfvarson J
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(2):154-162
Short and long-term efficacy of adalimumab in ulcerative colitis: a real-life study
Angelison L; Almer S; Davidsdottir L; Hammarlund P; Lindgren S; Hindorf U; Marsal J; Hertervig E
Journal article: JOURNAL OF CROHNS & COLITIS. 2020;14(Supplement_1):s576-s577
P714 Real-world effectiveness of vedolizumab in ulcerative colitis: Week 52 results from the Swedish multi-centre, prospective, observational SVEAH UC study
ERIKSSON C; Rundquist S; Lykiardopoulos V; Udumyan R; Karlén P; Grip O; Söderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjöberg M; Öberg D; Bergemalm D; Hjortswang H; Halfvarson J
Journal article: JOURNAL OF TRANSLATIONAL SCIENCE. 2020;7(4)
Acute onset of inflammatory colitis in overlap with psoriatic arthritis and systemic lupus erythematosus following treatment with secukinumab
Almer S; Faustini F; Szczegielniak S; Gunnarsson I
Article: ARCHIVES OF ORAL BIOLOGY. 2019;107:104528
Salivary calprotectin is elevated in patients with active inflammatory bowel disease
Majster M; Almer S; Bostrom EA
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;49(9):1344-1355
Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation
Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Hoog C; Friberg D; Mjosberg J
Journal article: JOURNAL OF IMMUNOLOGY. 2019;202(1_Supplement):65.6
Heterogeneity in differentiation capacity among ILC precursors in human peripheral blood and tissues
Kokkinou E; Gutierrez-Perez I; Pandey RV; Rao A; Mazzurana L; Almer S; Höög C; Lindforss U; Bryceson Y; Mjösberg J
Journal article: JOURNAL OF IMMUNOLOGY. 2019;202(1_Supplement):187.10
Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3–ILC1/NK cell transdifferentiation
Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Höög C; Friberg D; Mjösberg J
Article: GUT. 2019;68(3):423-433
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study
Burisch J; Kiudelis G; Kupcinskas L; Kievit HAL; Andersen KW; Andersen V; Salupere R; Pedersen N; Kjeldsen J; D'Inca R; Valpiani D; Schwartz D; Odes S; Olsen J; Nielsen KR; Vegh Z; Lakatos PL; Toca A; Turcan S; Katsanos KH; Christodoulou DK; Fumery M; Gower-Rousseau C; Zammit SC; Ellul P; Eriksson C; Halfvarson J; Magro FJ; Duricova D; Bortlik M; Fernandez A; Hernandez V; Myers S; Sebastian S; Oksanen P; Collin P; Goldis A; Misra R; Arebi N; Kaimakliotis IP; Nikuina I; Belousova E; Brinar M; Cukovic-Cavka S; Langholz E; Munkholm P; Niewiadomski O; Bell S; Turk N; Cukovic-Cavka S; Kaimakliotis I; Nicolaou A; Duricova D; Lukas M; Bortlik M; Shonova O; Burisch J; Munkholm P; Langholz E; Blichfeldt B; Marker D; Carlsen K; Weimers P; Pedersen N; Kjeldsen J; Aalykke C; Dahlerup JF; Kudsk K; Andersen V; Vind I; Thorsgaard N; Salupere R; Olsen J; Nielsen KR; Oksanen P; Collin P; Katsanos KH; Christodoulou DK; Skamnelos A; Politis D; Ladefoged K; Lakatos PL; Vegh Z; Lakatos L; Demenyi P; Kramli SN; O'Morain C; Dal Piaz G; Santini A; Girardin G; D'Inca R; Schwartz D; Odes S; Kupcinskas L; Jonaitis L; Kiudelis G; Valantiene I
Article: DIGESTIVE AND LIVER DISEASE. 2019;51(2):253-257
Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine
Giannakopoulos G; Verbaan H; Friis-Liby I-L; Sangfelt P; Nyhlin N; Almer S
Article: JOURNAL OF CROHNS & COLITIS. 2019;13(1):67-78
Distinct Alterations in the Composition of Mucosal Innate Lymphoid Cells in Newly Diagnosed and Established Crohn's Disease and Ulcerative Colitis
Forkel M; van Tol S; Hoog C; Michaelsson J; Almer S; Mjosberg J
Journal article: GASTROENTEROLOGY. 2019;156(1):11-14
Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones
de Boer NKH
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2018;30(11):1297-1303
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study
Zammit SC; Ellul P; Girardin G; Valpiani D; Nielsen KR; Olsen J; Goldis A; Lazar D; Shonova O; Novakova M; Sebastian S; Whitehead E; Carmona A; Martinez-Cadilla J; Dahlerup JF; Kievit ALH; Thorsgaard N; Katsanos KH; Christodoulou DK; Magro F; Salupere R; Pedersen N; Kjeldsen J; Carlsen K; Ioannis K; Bergemalm D; Halfvarson J; Duricova D; Bortlik M; Collin P; Oksanen P; Kiudelis G; Kupcinskas L; Kudsk K; Andersen V; O'Morain C; Bailey Y; Doron S; Shmuel O; Almer S; Arebi N; Misra R; Cukovic-Cavka S; Brinar M; Munkholm P; Vegh Z; Burisch J
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2018;53(6):677-684
Infliximab restores colonic barrier to adherent-invasive E-coli in Crohn's disease via effects on epithelial lipid rafts
Yakymenko O; Schoultz I; Gullberg E; Strom M; Almer S; Wallon C; Wang A; Keita AV; Campbell BJ; McKay DM; Soderholm JD
Journal article: GASTROENTEROLOGY. 2018;154(6):s-841
Mo1892 - Clinical Effectiveness of Vedolizumab: Interim Analysis of the Swedish Observational Study on Vedolizumab Assessing Effectiveness and Healthcare Resource Utilization in Patients with Crohn's Disease (Sveah CD)
Eriksson C; Rundquist S; Lykiardopoulos V; Karlén P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjöberg M; Öberg D; Bergemalm D; Udumyan R; Hjortswang H; Group TSSS; Halfvarson J
Journal article: GASTROENTEROLOGY. 2018;154(6):s-842
Mo1894 - Clinical Effectiveness of Vedolizumab: Interim Analysis of the Swedish Observational Study on Vedolizumab Assessing Effectiveness and Healthcare Resource Utilization in Patients with Ulcerative Colitis (Sveah UC)
Eriksson C; Rundquist S; Lykiardopoulos V; Karlén P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjöberg M; Öberg D; Bergemalm D; Udumyan R; Hjortswang H; Group TSSS; Halfvarson J
Journal article: JOURNAL OF CROHNS & COLITIS. 2018;12(suppl_1):s494-s495
P758 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn’s disease (SVEAH CD)
Eriksson C; Rundquist S; Lykiardopoulos V; Karlén P; Grip O; Söderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjöberg M; Öberg D; Bergemalm D; Udumyan R; Hjortswang H; Group TSSS; Halfvarson J
Journal article: JOURNAL OF CROHNS & COLITIS. 2018;12(supplement_1):s409-s410
P595 Clinical effectiveness of golimumab: Interim analysis of the observational study of patients with ulcerative colitis on golimumab in the Swedish National Quality Registry for IBD–GO-SWIBREG
Eriksson C; Bergemalm D; Vigren L; Nilsson L; Visuri I; Hjortswang H; Udumyan R; Almer S; Seddighzadeh M; Hertervig E; Karlén P; Strid H; Halfvarson J; group TG-SS
Journal article: JOURNAL OF CROHNS & COLITIS. 2018;12(supplement_1):s382-s383
P547 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)
Eriksson C; Rundquist S; Lykiardopoulos V; Karlén P; Grip O; Söderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjöberg M; Öberg D; Bergemalm D; Udumyan R; Hjortswang H; Group TSSS; Halfvarson J
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2018;141(1):279-292
Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells
Konya V; Czarnewski P; Forkel M; Rao A; Kokkinou E; Villablanca EJ; Almer S; Lindforss U; Friberg D; Hoeoeg C; Bergman P; Mjoesberg J
Article: DIGESTIVE DISEASES AND SCIENCES. 2018;63(1):105-112
Genetic Variation and Gene Expression Levels of Tight Junction Genes Indicates Relationships Between PTEN as well as MAGI1 and Microscopic Colitis
Noren E; Mellander M-R; Almer S; Soderman J
Article: JOURNAL OF CROHNS & COLITIS. 2017;11(10):1213-1222
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom Study
Burisch J; Vegh Z; Katsanos KH; Christodoulou DK; Lazar D; Goldis A; O'Morain C; Fernandez A; Pereira S; Myers S; Sebastian S; Pedersen N; Olse J; Nielsen KR; Schwartz D; Odes S; Almer S; Halfvarson J; Turk N; Cukovic-Cavka S; Nikulina I; Belousova E; Duricova D; Bortlik M; Shonova O; Salupere R; Barros L; Magro F; Jonaitis L; Kupcinskas L; Turcan S; Kaimakliotis I; Ladefoged K; Kudsk K; Andersen V; Vind I; Thorsgaard N; Oksanen P; Collin P; Dal Piaz G; Santini A; Niewiadomski O; Bell S; Moum B; Arebi N; Kjeldsen J; Carlsen K; Langholz E; Lakatos PL; Munkholm P; Gerdes LU; Dahlerup JF
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2017;18(8):E1827-1827
Systemic Chemokine Levels with "Gut-Specific" Vedolizumab in Patients with Inflammatory Bowel DiseaseA Pilot Study
Zwicker S; Lira-Junior R; Hoog C; Almer S; Bostrom EA
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2017;52(6-7):722-729
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Eriksson C; Marsal J; Bergemalm D; Vigren L; Bjork J; Eberhardson M; Karling P; Soderman C; Myrelid P; Cao Y; Sjoberg D; Thorn M; Karlen P; Hertervig E; Strid H; Ludvigsson JF; Almer S; Halfvarson J
Article: GASTROENTEROLOGY. 2017;152(8):1975-1984.e8
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Weismueller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Faerkkilae MA; Marschall H-U; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouilleres O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; de Valle MB; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM
Article: BMC GASTROENTEROLOGY. 2017;17(1):68
Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease
Noren E; Almer S; Soderman J
Article: GUT. 2017;66(3):421-428
Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis
Westerlind H; Mellander M-R; Bresso F; Munch A; Bonfiglio F; Assadi G; Rafter J; Huebenthal M; Lieb W; Kallberg H; Brynedal B; Padyukov L; Halfvarson J; Torkvist L; Bjork J; Andreasson A; Agreus L; Almer S; Miehlke S; Madisch A; Ohlsson B; Lofberg R; Hultcrantz R; Franke A; D'Amato M
Journal article: JOURNAL OF CROHNS & COLITIS. 2017;11(suppl_1):s262-s263
P364 A Swedish observational study (SVEAH) on vedolizumab assessing effectiveness and healthcare resource utilization in patients with inflammatory bowel disease
Eriksson C; Lykiardopoulos B; Karlén P; Grip O; Söderman C; Almer S; Hertervig E; Gunnarsson J; Delin J; Strid H; Sjöberg M; Öberg D; Hjortswang H; Halfvarson J; Group TSSS
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2017;45(4):519-532
Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients
Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thorn M; Bjork J; Hindorf U; Lofberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E
Article: JOURNAL OF CROHNS & COLITIS. 2017;11(1):3-25
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Gomollon F; Dignass A; Annese V; Tilg H; Van Assche G; Lindsay JO; Peyrin-Biroulet L; Cullen GJ; Daperno M; Kucharzik T; Rieder F; Almer SO; Armuzzi A; Harbord M; Langhorst J; Sans M; Chowers Y; Fiorino G; Juillerat P; Mantzaris GJ; Rizzello F; Vavricka S; Gionchetti P
Article: PLOS ONE. 2017;12(3):e0173825
Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism
Haglund S; Vikingsson S; Almer S; Soderman J
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2016;28(11):1320-1328
Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study
Oxelmark L; Lindberg A; Lofberg R; Sternby B; Eriksson A; Almer S; Befrits R; Fossum B; Karlen P; Brostrom O; Tysk C
Article: NATURE COMMUNICATIONS. 2016;7:12321
Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth
Gerling M; Buller NVJA; Kirn LM; Joost S; Frings O; Englert B; Bergstrom A; Kuiper RV; Blaas L; Wielenga MCB; Almer S; Kuhl AA; Fredlund E; van den Brink GR; Toftgard R
Article: NATURE COMMUNICATIONS. 2016;7:11314
FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice
Bosma M; Gerling M; Pasto J; Georgiadi A; Graham E; Shilkova O; Iwata Y; Almer S; Soderman J; Toftgard R; Wermeling F; Bostrom EA; Bostrom PA
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2016;51(4):479-485
Pregnancy and childbirth in women with autoimmune hepatitis is safe, even in compensated cirrhosis
Borssen AD; Wallerstedt S; Nyhlin N; Bergquist A; Lindgren S; Almer S; Werner M
Article: ANNALS OF TRANSPLANTATION. 2016;21:56-67
Single Nucleotide Polymorphisms in MORC4, CD14, and TLR4 Are Related to Outcome of Allogeneic Stem Cell Transplantation
Noren E; Verma D; Soderkvist P; Weisselberg T; Soderman J; Lotfi K; Almer S
Article: PLOS ONE. 2016;11(11):e0167324
Receptor-Type Protein-Tyrosine Phosphatase ζ and Colony Stimulating Factor-1 Receptor in the Intestine: Cellular Expression and Cytokine- and Chemokine Responses by Interleukin-34 and Colony Stimulating Factor-1
Zwicker S; Bureik D; Bosma M; Martinez GL; Almer S; Bostrom EA
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2015;50(8):991-1001
Effects of anti-inflammatory therapy on bursting pressure of colonic anastomosis in murine dextran sulfate sodium induced colitis
Myrelid P; Salim SY; Darby T; Almer S; Melgar S; Andersson P; Soderholm JD
Article: CLINICAL SCIENCE. 2015;129(3):281-290
Interleukin 34: a new modulator of human and experimental inflammatory bowel disease
Zwicker S; Martinez GL; Bosma M; Gerling M; Clark R; Majster M; Soderman J; Almer S; Bostrom EA
Article: JOURNAL OF MAGNETIC RESONANCE IMAGING. 2015;42(2):468-476
Consistent intensity inhomogeneity correction in water-fat MRI
Andersson T; Romu T; Karlsson A; Noren B; Forsgren MF; Smedby O; Kechagias S; Almer S; Lundberg P; Borga M; Leinhard OD
Journal article: GASTROENTEROLOGY. 2015;148(4):s-871
Tu1368 Vedolizumab in Inflammatory Bowel Disease, the First Experience From the Swedish IBD Registry (SWIBREG)
Eriksson C; Almer S; Björk JA; Eberhardson M; Eriksson A; Grip O; Hertervig E; Höög C; Jäghult S; Karlén P; Ludvigsson J; Marsal J; Sjöberg D; Stjernman H; Strid H; Thörn M; Vigren L; Hjortswang H; Halfvarson J
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2015;50(2):217-223
Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients
Borssen AD; Almer S; Prytz H; Wallerstedt S; Friis-Liby I-L; Bergquist A; Nyhlin N; Hultcrantz R; Sangfelt P; Weiland O; Lindgren S; Verbaan H; Werner M
Article: EUROPEAN JOURNAL OF RADIOLOGY OPEN. 2015;2:19-25
Visual assessment of biliary excretion of Gd-EOB-DTPA in patients with suspected diffuse liver disease - A biopsy-verified prospective study.
Norén B; Dahlström N; Forsgren MF; Dahlqvist Leinhard O; Kechagias S; Almer S; Wirell S; Smedby Ö; Lundberg P
Article: BIOMED RESEARCH INTERNATIONAL. 2015;2015:834805-10
Gene Expression-Genotype Analysis Implicates GSDMA, GSDMB, and LRRC3C as Contributors to Inflammatory Bowel Disease Susceptibility
Soderman J; Berglind L; Almer S
Article: INFLAMMATORY BOWEL DISEASES. 2015;21(1):121-131
Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study
Burisch J; Vardi H; Pedersen N; Brinar M; Cukovic-Cavka S; Kaimakliotis I; Duricova D; Bortlik M; Shonova O; Vind I; Avnstrom S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Bailey Y; O'Morain C; Schwartz D; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Pineda JR; Almer S; Halfvarson J; Tsai H-H; Sebastian S; Friger M; Greenberg D; Lakatos PL; Langholz E; Odes S; Munkholm P
Article: JOURNAL OF CROHNS & COLITIS. 2014;8(12):1702-1709
Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease
Vikingsson S; Andersson D; Almer S; Peterson C; Hindorf U
Article: JOURNAL OF CROHNS & COLITIS. 2014;8(9):1030-1042
Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease - An ECCO-EpiCom study
Burisch J; Weimers P; Pedersen N; Cukovic-Cavka S; Vucelic B; Kaimakliotis I; Duricova D; Bortlik M; Shonova O; Vind I; Avnstrom S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Bjornsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Valpiani D; Boni MC; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Sanroman L; Almer S; Zhulina Y; Halfvarson J; Arebi N; Diggory T; Sebastian S; Lakatos PL; Langholz E; Munkholm P
Article: JOURNAL OF CROHNS & COLITIS. 2014;8(8):811-818
Health care and patients' education in a European inflammatory bowel disease inception cohort: An ECCO-EpiCom study
Burisch J; Vegh Z; Pedersen N; Cukovic-Cavka S; Turk N; Kaimakliotis I; Duricova D; Bortlik M; Shonova O; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Ragnarsson G; Bjornsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Politi SP; Santini A; Kiudelis G; Kupcinskas L; Turcan S; Magro F; Barros L; Lazar D; Goldis A; Nikulina I; Belousova E; Sanroman L; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Houston Y; Sebastian S; Langholz E; Lakatos PL; Munkholm P
Article: THROMBOSIS RESEARCH. 2014;134(2):455-461
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby I-L; Kapraali M; Kechagias S; Lindahl TL; Almer S
Article: JOURNAL OF CROHNS & COLITIS. 2014;8(7):607-616
Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe - An ECCO-EpiCom study
Burisch J; Pedersen N; Cukovic-Cavka S; Turk N; Kaimakliotis I; Duricova D; Bortlik M; Shonova O; Vind I; Avnstrom S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Bjornsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Giannotta M; Girardin G; Kiudelis G; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Martinez-Ares D; Hernandez V; Almer S; Zhulina Y; Halfvarson J; Arebi N; Tsai HH; Sebastian S; Lakatos PL; Langholz E; Munkholm P
Article: JOURNAL OF HEPATOLOGY. 2014;60(6):1259-1267
Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids
Wang L; Hartmann P; Haimerl M; Bathena SP; Sjowall C; Almer S; Alnouti Y; Hofmann AF; Schnabl B
Article: GUT. 2014;63(4):588-597
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort
Burisch J; Pedersen N; Cukovic-Cavka S; Brinar M; Kaimakliotis I; Duricova D; Shonova O; Vind I; Avnstrom S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Bjornsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'lnca R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2014;26(3):295-300
Faecal analysis and plasma complement factor 3c levels at admission for an acute attack of ulcerative colitis are predictive of the need for colectomy
Pagoldh M; Lange S; Jennische E; Almer S; Bostrom EA; Eriksson A
Journal article: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY RESEARCH. 2014;3(12):1396-1400
Current Practice of Anti-TNF-α Treatment in Inflammatory Bowel Disease: Results From A National Survey in Sweden
Hindorf U; Almer S
Article: INFLAMMATORY BOWEL DISEASES. 2014;20(1):36-46
Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort
Burisch J; Pedersen N; Cukovic-Cavka S; Turk N; Kaimakliotis I; Duricova D; Shonova O; Vind I; Avnstrom S; Thorsgaard N; Krabbe S; Andersen V; Jens FD; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Bailey Y; O'Morain C; Schwartz D; Odes S; Martinato M; Lombardini S; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Hernandez V; Almer S; Zhulina Y; Halfvarson J; Tsai H-H; Sebastian S; Lakatos PL; Langholz E; Munkholm P
Article: WORLD JOURNAL OF GASTROENTEROLOGY. 2013;19(30):4935-4943
Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease
Soderman J; Noren E; Christiansson M; Bragde H; Thiebaut R; Hugot J-P; Tysk C; O'Morain CA; Gassull M; Finkel Y; Colombel J-F; Lemann M; Almer S
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2013;38(4):377-387
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients
Sjoberg M; Magnuson A; Bjork J; Benoni C; Almer S; Friis-Liby I; Hertervig E; Olsson M; Karlen P; Eriksson A; Midhagen G; Carlson M; Lapidus A; Halfvarson J; Tysk C
Journal article: JOURNAL OF HEPATOLOGY. 2013;58:s382-s383
927 RISK FOR HEPATOCELLULAR CARCINOMA IN AUTOIMMUNE HEPATITIS – IS THERE AN INDICATION FOR SURVEILLANCE?
Borssén ÅD; Lindgren S; Bergquist A; Almer S; Sangfelt P; Werner M; SILK
Article: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2013;75:145-152
Monitoring of thiopurine metabolites - A high-performance liquid chromatography method for clinical use
Vikingsson S; Almer S; Peterson C; Carlsson B; Josefsson M
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2013;48(3):358-365
Moderate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis
Wallerstedt S; Simren M; Wahlin S; Loof L; Hultcrantz R; Sjoberg K; Gertzen HS; Prytz H; Almer S; Oden A
Journal article: JOURNAL OF CROHNS & COLITIS. 2013;7(Supplement_1):s282
P677 Gasdermin B (GSDMB) is implicated as a contributor to IBD susceptibility
Söderman J; Berglind L; Almer S
Journal article: JOURNAL OF CROHNS & COLITIS. 2013;7(Supplement_1):s265
P634 Incidence of microscopic colitis 2008–2011 in central Östergötland, Sweden. Evidence for an increase?
Daferera N; Almer S; Münch A
Journal article: JOURNAL OF CROHNS & COLITIS. 2013;7(Supplement_1):s224
P533 Excellent long-term outcome in infliximab treated patients with chronic active ulcerative colitis
Angelison L; Almer S; Hindorf U; Hertervig E
Journal article: JOURNAL OF CROHNS & COLITIS. 2013;7(Supplement_1):s282-s283
P678 Relation between a single nucleotide polymorphism in MORC4, NOD2 variants and outcome after allogeneic stem cell transplantation for haematological malignancies
Norén E; Verma D; Söderman J; Lotfi K; Almer S
Journal article: ADVANCES IN BIOSCIENCE AND BIOTECHNOLOGY. 2013;04(08):33-42
Differences in the expression of hepatocyte growth factor in acute and chronic bowel inflammation—Implications for diagnosis?
Lönn J; Nakka S; Olsson H; Bengtsson T; Almer S; Nayeri F
Article: PLOS ONE. 2013;8(2):e56989
Gene Expression and Thiopurine Metabolite Profiling in Inflammatory Bowel Disease - Novel Clues to Drug Targets and Disease Mechanisms?
Haglund S; Almer S; Peterson C; Soederman J
Article: EUROPEAN RADIOLOGY. 2013;23(1):174-181
Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA
Noren B; Forsgren MF; Leinhard OD; Dahlstrom N; Kihlberg J; Romu T; Kechagias S; Almer S; Smedby O; Lundberg P
Journal article: GASTROENTEROLOGY. 2012;142(5):s-569-s-570
Mo1004 Is There an East-West Gradient in the Incidence of IBD in Europe? and Further Far East in China? First Results From the Epicom Study
Burisch J; Xia B; Cukovic-Cavka S; Kaimakliotis J; Duricova D; Shonova O; Vind I; Pedersen N; Langholz E; Thorsgaard N; Andersen V; Dahlerup JF; Salupere R; Nielsen KR; Manninen P; Tsianos EV; Ladefoged K; Bjornsson E; Bailey Y; Odes SH; Martinato M; Kupcinskas L; Turcan SI; Magro F; Goldis A; Belousova E; Hernandez V; Almer S; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Munkholm PS
Article: HUMAN IMMUNOLOGY. 2012;73(4):382-388
High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation
Sjowall C; Cardell K; Bostrom EA; Bokarewa MI; Enocsson H; Ekstedt M; Lindvall L; Fryden A; Almer S
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2011;74(5):463-470
Resistin is Associated with Breach of Tolerance and Anti-nuclear Antibodies in Patients with Hepatobiliary Inflammation
Bostrom EA; Ekstedt M; Kechagias S; Sjowall C; Bokarewa MI; Almer S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2011;46(9):1118-1126
Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population
Aleman S; Endalib S; Stal P; Loof L; Lindgren S; Sandberg-Gertzen H; Almer S; Olsson S; Danielsson A; Wallerstedt S; Hultcrantz R
Article: JOURNAL OF CROHNS & COLITIS. 2011;5(4):342-349
Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe An EpiCom study
Burisch J; Cukovic-Cavka S; Kaimakliotis I; Shonova O; Andersen V; Dahlerup JF; Elkjaer M; Langholz E; Pedersen N; Salupere R; Kolho K-L; Manninen P; Lakatos PL; Shuhaibar M; Odes S; Martinato M; Mihu I; Magro F; Belousova E; Fernandez A; Almer S; Halfvarson J; Hart A; Munkholm P
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2011;23(8):671-679
Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease
Stjernman H; Tysk C; Almer S; Strom M; Hjortswang H
Journal article: GASTROENTEROLOGY. 2011;140(5):s-590
Infliximab as Rescue Therapy in Steroid-Refractory Acute Ulcerative Colitis; A Retrospective Follow-up Study
Sjöberg M; Almer S; Befrits R; Benoni C; Carlson M; Eriksson A; Friis-Liby I; Halfvarson J; Hertervig E; Karlen P; Lapidus AB; Magnuson A; Midhagen G; Tysk C
Article: THERAPEUTIC DRUG MONITORING. 2011;33(2):200-208
The Role of Inosine-5′-Monophosphate Dehydrogenase in Thiopurine Metabolism in Patients With Inflammatory Bowel Disease
Haglund S; Vikingsson S; Soderman J; Hindorf U; Granno C; Danelius M; Coulthard S; Peterson C; Almer S
Article: DIGESTIVE AND LIVER DISEASE. 2011;43(4):270-276
Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease-Proceedings of the first Thiopurine Task Force meeting
van Asseldonk DP; Sanderson J; de Boer NKH; Sparrow MP; Lemann M; Ansari A; Almer SH; Florin THJ; Gearry RB; Mulder CJ; Mantzaris G; van Bodegraven AA
Article: NATURE GENETICS. 2011;43(1):43-47
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease
Momozawa Y; Mni M; Nakamura K; Coppieters W; Almer S; Amininejad L; Cleynen I; Colombel J-F; de Rijk P; Dewit O; Finkel Y; Gassull MA; Goossens D; Laukens D; Lemann M; Libioulle C; O'Morain C; Reenaers C; Rutgeerts P; Tysk C; Zelenika D; Lathrop M; Del-Favero J; Hugot J-P; de Vos M; Franchimont D; Vermeire S; Louis E; Georges M
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2010;32(9):1154-1162
The epidemiology and clinical features of portal vein thrombosis: a multicentre study
Rajani R; Bjornsson E; Bergquist A; Danielsson A; Gustavsson A; Grip O; Melin T; Sangfelt P; Wallerstedt S; Almer S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2010;45(6):696-706
Worries and concerns in a large unselected cohort of patients with Crohn's disease
Stjernman H; Tysk C; Almer S; Strom M; Hjortswang H
Journal article: CANCER RESEARCH. 2010;70(8_Supplement):2601
Abstract 2601: What do we actually measure during therapeutic drug monitoring of thiopurine treatment in acute lymphoblastic leukemia and inflammatory bowel disease
Vikingsson S; Carlsson B; Almer S; Peterson C
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2010;45(4):457-467
Characteristics and long-term outcome of patients with autoimmune hepatitis related to the initial treatment response
Werner M; Wallerstedt S; Lindgren S; Almer S; Bjornsson E; Bergquist A; Prytz H; Sandberg-Gertzen H; Hultcrantz R; Sangfelt P; Weiland O; Ohlsson B; Danielsson A
Article: JOURNAL OF HEPATOLOGY. 2010;52(1):106-111
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis
Hindorf U; Jahed K; Bergquist A; Verbaan H; Prytz H; Wallerstedt S; Werner M; Olsson R; Bjoernsson E; Peterson C; Almer SHC
Article: INFLAMMATORY BOWEL DISEASES. 2009;15(12):1859-1866
Factors Predicting the Outcome of Disease Activity Assessment in Crohn's Disease
Stjernman H; Tysk C; Almer S; Strom M; Hjortswang H
Article: INFLAMMATORY BOWEL DISEASES. 2009;15(12):1882-1890
Resource Use and Societal Costs for Crohn's Disease in Sweden
Mesterton J; Jonsson L; Almer SHC; Befrits R; Friis-Liby I; Lindgren S
Article: GASTROENTEROLOGY. 2009;137(4):1301-1309
Increased Mortality Risk in Patients With Phenotypic Hereditary Hemochromatosis But Not in Their First-Degree Relatives
Elmberg M; Hultcrantz R; Ebrahim F; Olsson S; Lindgren S; Loof L; Stal P; Wallerstedt S; Almer S; Sandberg-Gertzen H; Ekbom A; Askling J
Journal article: JOURNAL OF CROHNS & COLITIS. 2009;3(1):4
P006 RICK/RIP2 POLYMORPHISMS IN INFLAMMATORY BOWEL DISEASES
Thiébaut R; Douchin V; Merlin F; Colombel J; Lemann M; Almer S; Tysk C; Omorain M; Gassull M; Binder V; Finkel Y; Jung C; Pascoe L; Hugot J
Article: DISEASES OF THE COLON & RECTUM. 2009;52(8):1387-1394
Thiopurine Therapy Is Associated with Postoperative Intra-Abdominal Septic Complications in Abdominal Surgery for Crohn's Disease
Myrelid P; Olaison G; Sjodahl R; Nystrom P-O; Almer S; Andersson P
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2009;20(4):398-402
Transitions between variant forms of primary biliary cirrhosis during long-term follow-up
Lindgren S; Glaumann H; Almer S; Bergquist A; Bjornsson E; Broome U; Danielsson A; Lebrun B; Prytz H; Olsson R
Article: THERAPEUTIC DRUG MONITORING. 2009;31(3):345-350
Monitoring of Thiopurine Metabolites in Patients With Inflammatory Bowel Disease-What Is Actually Measured?
Vikingsson S; Carlsson B; Almer SHC; Peterson C
Journal article: GASTROENTEROLOGY. 2009;136(5):a-854
T1871 The Prevalence of Elevated IgG4 Levels in Patients with Primary Sclerosing Cholangitis
Bjornsson E; Almer SH; Prytz H; Werner M; Sangfelt P; Rajani R
Journal article: GASTROENTEROLOGY. 2009;136(5):a-209
S1187 Genetic Association Between Crohn's Disease and a Marker Located in the Region of Claudin 2 Implicates the Intestinal Barrier As a Primary Risk Factor in a Swedish Population
Slånemyr E; Taipalensuu J; Christiansson M; Andreasson H; Thiébaut R; Hugot J-P; Tysk C; O'Morain CA; Gassull M; Finkel Y; Colombel J-F; Lémann M; Almer SH
Journal article: GASTROENTEROLOGY. 2009;136(5):a-678
W1208 A ‘Skewed’ Thiopurine Metabolite Profile in IBD Patients Is Not Explained By Variations in Inosine-5-Monophosphate Dehydrogenase Activity
Haglund S; Vikingsson S; Taipalensuu J; Coulthard S; Hindorf U; Danelius M; Peterson C; Almer SH
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2009;29(6):654-661
Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease
Hindorf U; Johansson M; Eriksson A; Kvifors E; Almer SHC
Article: DIGESTIVE AND LIVER DISEASE. 2009;41(3):194-200
6-Thioguanine therapy in Crohn's disease-Observational data in Swedish patients
Almer SHC; Hjortswang H; Hindorf U
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2009;20(2):190-196
High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis
Olsson R; Glaumann H; Almer S; Broome U; Lebrun B; Bergquist A; Bjornsson E; Prytz H; Danielsson A; Lindgren S
Journal article: JOURNAL OF CROHNS & COLITIS. 2009;3(1):s84-s85
P189 - Is inosine-5′-monophosphate dehydrogenase of importance in thiopurine treated patients who display a “skewed” metabolite profile?
Haglund S; Taipalensuu J; Vikingsson S; Coulthard S; Peterson C; Hindorf U; Danelius M; Almer S
Journal article: JOURNAL OF CROHNS & COLITIS. 2009;3(1):s112-s113
P257 - Genetic association between Crohn's disease and a marker located in the region of claudin 2 implicates the intestinal barrier as a primary risk factor in a Swedish population
Slånemyr E; Taipalensuu J; Christiansson M; Andreasson H; Thiébaut R; Hugot J; Tysk C; O'Morain C; Gassull M; Binder V; Finkel Y; Colombel JF; Lémann M; Almer S
Article: LIVER INTERNATIONAL. 2009;29(2):253-259
Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experience
Rajani R; Melin T; Bjornsson E; Broome U; Sangfelt P; Danielsson A; Gustavsson A; Grip O; Svensson H; Loof L; Wallerstedt S; Almer SHC
Article: JOURNAL OF HEPATOLOGY. 2009;50(2):388-393
Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients
Werner M; Almer S; Prytz H; Lindgren S; Wallerstedt S; Bjoersson E; Bergquist A; Sandberg-Gertzen H; Hultcrantz R; Sangfelt P; Weiland O; Danielsson A
Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2009;104(2):384-391
TNFSF15 Polymorphisms Are Associated With Susceptibility to Inflammatory Bowel Disease in a New European Cohort
Thiebaut R; Kotti S; Jung C; Merlin F; Colombel JF; Lemann M; Almer S; Tysk C; O'Morain M; Gassull M; Binder V; Finkel Y; Pascoe L; Hugot J-P
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2008;6(8):939-943
Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Loof L; Sandberg-Gertzen H; Almer S; Askling J; Ehlin A; Ekbom A
Article: EUROPEAN JOURNAL OF RADIOLOGY. 2008;66(2):313-320
Separation of advanced from mild fibrosis in diffuse liver disease using ³¹P magnetic resonance spectroscopy
Noren B; Dahlqvist O; Lundberg P; Almer S; Kechagias S; Ekstedt M; Franzen L; Wirell S; Smedby O
Journal article: JOURNAL OF CROHNS & COLITIS. 2008;2(1):28
P077 DEMOGRAPHIC AND DISEASE-RELATED FACTORS INFLUENCING ASSESSMENT OF DISEASE ACTIVITY IN CROHN'S DISEASE
Stjernman HCR; Tysk C; Almer S; Ström M; Hjortswang H
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2008;65(1):69-77
IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations
Haglund S; Taipalensuu J; Peterson C; Almer S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2008;43(10):1232-1240
Epidemiology and the initial presentation of autoimmune hepatitis in Sweden:: A nationwide study
Werner M; Prytz H; Ohlsson B; Almer S; Bjornsson E; Bergquist A; Wallerstedt S; Sandberg-Gertzen H; Hultcrantz R; Sangfelt P; Weiland O; Danielsson A
Article: PHARMACOGENETICS AND GENOMICS. 2007;17(10):891-895
Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23
Lindqvist M; Skoglund K; Karlgren A; Soderkvist P; Peterson C; Kidhall I; Almer S
Article: JOURNAL OF INTERNAL MEDICINE. 2007;262(3):393-401
Acute liver failure in Sweden:: etiology and outcome
Wei G; Bergquist A; Broome U; Lindgren S; Wallerstedt S; Almer S; Sangfelt P; Danielsson A; Sandberg-Gertzen H; Loof L; Prytz H; Bjornsson E
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2007;42(8):986-991
Autoimmune hepatitis among fertile women:: Strategies during pregnancy and breastfeeding?
Werner M; Bjornsson E; Prytz H; Lindgren S; Almer S; Broome U; Wallerstedt S; Sandberg-Gertzen H; Hultcrantz R; Sangfeldt P; Nilsson J; Danielsson A
Article: INFLAMMATORY BOWEL DISEASES. 2007;13(2):164-174
Leukocyte scintigraphy compared to intraoperative small bowel enteroscopy and laparotomy findings in Crohn's disease
Almer S; Granerus G; Strom M; Olaison G; Bonnet J; Lemann M; Smedh K; Franzen L; Bertheau P; Cattan P; Rain J-D; Modigliani R
Article: LAKARTIDNINGEN. 2007;104(4):210-213
[Acute liver failure--rapid multidisciplinary management].
Björnsson E; Wei G; Bergquist A; Broomé U; Wallerstedt S; Almer S; Sangfelt P; Danielsson A; Sandberg-Gertzén H; Lööf L; Prytz H; Lindgren S
Article: WIENER KLINISCHE WOCHENSCHRIFT. 2007;119(17-18):519-526
A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease
Teml A; Schwab M; Hommes DW; Almer S; Lukas M; Feichtenschlager T; Florin T; Seiderer J; Petritsch W; Bokemeyer B; Kreisel W; Herrlinger KR; Knoflach P; Bonaz B; Klugmann T; Herfarth H; Pedarnig N; Reinisch W
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2007;18(1):44-47
Abdominal tenderness in ascites patients indicates spontaneous bacterial peritonitis
Wallerstedt S; Olsson R; Simren M; Broome U; Wahlin S; Loof L; Hultcrantz R; Sjoberg K; Gertzen HS; Prytz H; Almer S
Journal article: CURRENT PHARMACOGENOMICS AND PERSONALIZED MEDICINE. 2006;4(4):285-300
Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring
Lindqvist M; Hindorf U; Almer S; Peterson C
Article: HEPATOLOGY. 2006;44(6):1572-1580
Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation
Prytz H; Keiding S; Bjornsson E; Broome U; Ahner S; Castedal M; Munk OL
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2006;41(10):1196-1203
The Short Health Scale:: A valid measure of subjective health in ulcerative colitis
Hjortswang H; Jarnerot G; Curman B; Sandberg-Gertzen H; Tysk C; Blomberg B; Almer S; Strom M
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2006;41(10):1190-1195
Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease
Myrelid P; Svarm S; Andersson P; Almer S; Bodemar G; Olaison G
Article: GUT. 2006;55(10):1423-1431
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
Hindorf U; Lindqvist M; Peterson C; Soderkvist P; Strom M; Hjortswang H; Pousette A; Almer S
Article: LIVER INTERNATIONAL. 2006;26(7):840-845
The AST/ALT ratio as an indicator of cirrhosis in patients with PBC
Nyblom H; Bjornsson E; Simren M; Aldenborg F; Almer S; Olsson R
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2006;41(8):934-943
Evaluation of the Inflammatory Bowel Disease Questionnaire in Swedish patients with Crohn's disease
Stjernman H; Granno C; Bodemar G; Jarnerot G; Ockander L; Tysk C; Blomberg B; Almer S; Strom M; Hjortswang H
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2006;24(2):331-342
Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease
Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
Article: DIGESTION. 2006;73(1):25-31
6-thioguanine treatment in inflammatory bowel disease:: A critical appraisal by a European 6-TG working party
de Boer NKH; Reinisch W; Teml A; van Bodegraven AA; Schwab M; Lukas M; Ochsenkühn T; Petritsch W; Knoflach P; Almer S; van der Merwe SW; Herrlinger KR; Seiderer J; Vogelsang H; Mulder CJJ
Article: BMC GASTROENTEROLOGY. 2005;5:13
Hepatocyte growth factor (HGF) in fecal samples:: rapid detection by surface plasmon resonance -: art. no. 13
Nayeri F; Aili D; Nayeri T; Xu JY; Almer S; Lundström I; Åkerlind B; Liedberg B
Article: EUROPEAN RADIOLOGY. 2005;15(1):148-157
Absolute quantification of human liver metabolite concentrations by localized in vivo ³¹P NMR spectroscopy in diffuse liver disease
Norén B; Lundberg P; Ressner M; Wirell S; Almer S; Smedby Ö
Article: THERAPEUTIC DRUG MONITORING. 2004;26(6):673-678
Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy - Results from a large Swedish patient population
Hindorf U; Peterson C; Almer S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2004;39(5):454-458
Treatment of anaemia in inflammatory bowel disease with iron sucrose
Bodemar G; Kechagias S; Almer S; Danielson BG
Article: PHARMACOGENETICS AND GENOMICS. 2004;14(4):261-265
Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity
Lindqvist M; Haglund S; Almer S; Peterson C; Taipalensu J; Hertervig E; Lyrenäs E; Söderkvist P
Article: CLINICAL CHEMISTRY. 2004;50(2):288-295
Pyrosequencing of TPMT Alleles in a general Swedish population and in patients with inflammatory bowel disease
Haglund S; Lindqvist M; Almer S; Peterson C; Taipalensuu J
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2004;64(6):589-597
Stability of faecal hepatocyte growth factor determination
Nayeri F; Nilsson I; Brudin L; Almer S
Article: GASTROENTEROLOGY. 2003;125(6):1733-1741
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg M; Hultcrantz R; Ekbom A; Brandt L; Olsson S; Olsson R; Lindgren S; Lööf L; Stål P; Wallerstedt S; Almer S; Sandberg-Gertzén H; Askling J
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2003;15(9):1011-1020
The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis
Hjortswang H; Järnerot G; Curman B; Sandberg-Gertzén H; Tysk C; Blomberg B; Almer S; Ström M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(3):207-211
Real-time RT-PCR methodology for quantification of thiopurine methyltransferase gene expression
Lindqvist M; Almer S; Peterson C; Söderkvist P
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2003;11(2):179-184
Clustering of Crohn's disease within affected sibships
Hugot JP; Cézard JP; Colombel JF; Belaiche J; Almer S; Tysk C; Montague S; Gassull M; Christensen S; Finkel Y; Gower-Rousseau C; Modigliani R; Zouali H; Lesage S; Chamaillard M; Macry J; Thomas G; Victor JM
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2003;35(11-12):858-862
High hepatocyte growth factor levels in faeces during acute infectious gastroenteritis
Nayeri F; Almer S; Brudin L; Nilsson I; Åkerlind B; Forsberg P
Article: GUT. 2003;52(1):71-74
CARD4/NOD1 is not involved in inflammatory bowel disease
Zouali H; Lesage S; Merlin F; Cézard JP; Colombel JF; Belaiche J; Almer S; Tysk C; O'Morain C; Gassull M; Christensen S; Finkel Y; Modigliani R; Gower-Rousseau C; Macry J; Chamaillard M; Thomas G; Hugot JP
Article: JOURNAL OF AUTOIMMUNITY. 2002;19(3):155-160
Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjogren's syndrome, rheumatoid arthritis or inflammatory bowel disease
Sjöwall C; Eriksson P; Almer S; Skogh T
Article: THERAPEUTIC DRUG MONITORING. 2002;24(3):351-358
Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy:: Possible role of concomitant methotrexate
Pettersson B; Almer S; Albertioni F; Söderhäll S; Peterson C
Article: JOURNAL OF HEPATOLOGY. 2002;36(5):586-589
Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)
Broomé U; Glaumann H; Lindström E; Lööf L; Almer S; Prytz H; Sandberg-Gertzén H; Lindgren S; Fork FT; Järnerot G; Olsson R
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2002;70(4):845-857
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
Lesage S; Zouali H; Cézard JP; Colombel JF; Belaiche J; Almer S; Tysk C; O'Morain C; Gassull M; Binder V; Finkel Y; Modigliani R; Gower-Rousseau C; Macry J; Merlin F; Chamaillard M; Jannot AS; Thomas G; Hugot JP
Article: JOURNAL OF HEPATOLOGY. 2002;36(3):321-327
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist A; Ekbom A; Olsson R; Kornfeldt D; Lööf L; Danielsson Å; Hultcrantz R; Lindgren S; Prytz H; Sandberg-Gertzén H; Almer S; Granath F; Broomé U
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2001;9(10):731-742
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease
Zouali H; Chamaillard M; Lesage S; Cézard JP; Colombel JF; Belaiche J; Almer S; Tysk C; Montague S; Gassull M; Christensen S; Finkel Y; Gower-Rousseau C; Modigliani R; Macry J; Selinger-Leneman H; Thomas G; Hugot JP
Article: LAKARTIDNINGEN. 2001;98(23):2795
[Genetic breakthrough in inflammatory bowel disease].
Almer S
Journal article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2001;96(6):1822-1830
Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease
Levenstein S; Li Z; Almer S; Barbosa A; Marquis P; Moser G; Sperber A; Toner B; Drossman DA
Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2001;96(6):1822-1830
Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease
Levenstein S; Li ZM; Almer S; Barbosa A; Marquis P; Moser G; Sperber A; Toner B; Drossman DA
Article: NATURE. 2001;411(6837):599-603
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot JP; Chamaillard M; Zouali H; Lesage S; Cézard JP; Belaiche J; Almer S; Tysk C; O'Morain CA; Gassull M; Binder V; Finkel Y; Cortot A; Modigliani R; Laurent-Puig P; Gower-Rousseau C; Macry J; Colombel JF; Sahbatou M; Thomas G
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2001;36(1):77-85
Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis
Hjortswang H; Järnerot G; Curman B; Sandberg-Gertzén H; Tysk C; Blomberg B; Almer S; Ström M
Article: GUT. 2000;47(6):787-791
Genetic analyses of chromosome 12 loci in Crohn's disease
Lesage S; Zouali H; Colombel JF; Belaiche J; Cézard JP; Tysk C; Almer S; Gassull M; Binder V; Chamaillard M; Le Gall I; Thomas G; Hugot JP
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 1999;11(10):1099-1104
The network:: a strategy to describe the relationship between quality of life and disease activity.: The case of inflammatory bowel disease
Hjortswang H; Almer S; Ström M
Journal article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1999;28(5):558
MUTATION SCREENING IN THE CD19 AND CD43 (SIALOPHORIN) GENES IN CROHN DISEASE PATIENTS
Hugot JP; Zouali H; Colombel JF; Belaiche J; Cézard JP; Gassull M; Tysk C; Almer S; Binder V; Van Gossum A; Löfberg R; Parrello T; Montague S; Malchow H; Lesage S; Chamaillard M; Thomas G
Journal article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1999;28(5):558
MUTATION SCREENING IN THE CD19 AND CD43 (SIALOPHORIN) GENES IN CROHN DISEASE PATIENTS
Hugot JP; Zouali H; Colombel JF; Belaiche J; Cézard JP; Gassull M; Tysk C; Almer S; Binder V; Van Gossum A; Löfberg R; Parrello T; Montague S; Malchow H; Lesage S; Chamaillard M; Thomas G; Disease. ETGTEIT
Journal article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 1998;93(11):2203-2211
Health-related quality of life in Swedish patients with ulcerative colitis
Hjortswang H
Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 1998;93(11):2203-2211
Health-related quality of life in Swedish patients with ulcerative colitis
Hjortswang H; Ström M; Almer S
Journal article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1998;26(5):550
LINKAGE ANALYSIS OF CHROMOSOME 12 LOCI IN CROHN'S DISEASE FAMILIES.
Hugot JP; Lesage S; Colombel JF; Belaiche J; Card JP; A. VG; Löfberg R; Parrello T; Zouali H; C. G-R; Gendre JP; Thomas G
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 1998;33(4):423-429
Low symptomatic load in Crohn's disease with surgery and medicine as complementary treatments
Andersson P; Olaison G; Bodemar G; Almer S; Arvidsson M; Dabrosin-Söderholm J; Nyström PO; Smedh K; Ström M; Sjödahl R
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 1997;32(12):1235-1240
Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis
Hjortswang H; Ström M; Almeida RT; Almer S
Article: MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING. 1997;35(4):386-390
Technology assessment using the association between outcome measures and patterns of illness severity
Almeida RT; Hjortswang H; Strom M; Almer S; Persson J
Article: LANCET. 1996;347(9017):1731-1735
Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitis
Almer S; Bodemar G; Franzen L; Lindstrom E; Nystrom PO; Strom M
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 1996;23(6):669-674
Labelling of leucocytes with technetium-99m exametazime causes in vitro upregulation of granulocyte CD11b without correlation to tissue uptake in vivo
Almer S; Ljunghusen O; Lundahl J
Article: BRITISH JOURNAL OF SURGERY. 1996;162(5):391-396
Concentrations of platelet activating factor in rectal mucosa in patients with ulcerative colitis
Almer S; Kald B; Franzen L; Strom M; Tagesson C
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 1996;23(3):247-255
Technetium-99m scintigraphy: More accurate assessment of ulcerative colitis with exametazime-labelled leucocytes than with antigranulocyte antibodies
Almers S; Granerus G; Franzen L; Strom M
Article: DIGESTIVE DISEASES AND SCIENCES. 1995;40(9):1866-1872
PERINUCLEAR ANTINEUTROPHIL CYTOPLASMIC ANTIBODY AND REFRACTORY POUCHITIS - A CASE-CONTROL STUDY
AISENBERG J; WAGREICH J; SHIM J; ALMER S; PEEN E; HEIMANN T; GELERNT IM; GREENSTEIN A; RUBIN P; HARPAZ N; MAYER L; SACHAR D
Article: NUCLEAR MEDICINE COMMUNICATIONS. 1995;16(4):290-298
IS COMPUTER-AIDED INTERPRETATION OF TC-99(M)-HMPAO LEUKOCYTE SCANS BETTER THAN THE NAKED EYE
ALMER S; PETERS AM; EKBERG S; FRANZIN L; GRANERUS G; STROM M
Article: DIGESTION. 1995;56(6):528-533
PLAIN X-RAY-FILMS AND AIR ENEMA FILMS REFLECT SEVERE MUCOSAL INFLAMMATION IN ACUTE ULCERATIVE-COLITIS
ALMER S; BODEMAR G; FRANZEN L; LINDSTROM E; NOREN B; STROM M
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 1995;7(1):59-64
AIR ENEMA RADIOLOGY COMPARED WITH LEUKOCYTE SCINTIGRAPHY FOR IMAGING INFLAMMATION IN ACTIVE ULCERATIVE-COLITIS
ALMER S; BODEMAR G; LINDSTROM E; PETERS AM; STROM M
Journal article: LAKARTIDNINGEN. 1993;90(20):1954-1956
[Clostridium difficile enteritis complicated by symphysitis. Good effect of fecal streptococci].
Ohman L; Frydén A; Almer S; Tropp H
Journal article: GUT. 1993;34(4):509-513
INCREASED ABSORPTION OF POLYETHYLENE-GLYCOL 600 DEPOSITED IN THE COLON IN ACTIVE ULCERATIVE-COLITIS
ALMER S; FRANZEN L; OLAISON G; SMEDH K; STROM M
Journal article: GUT. 1993;34(1):56-62
ANTI-LACTOFERRIN ANTIBODIES AND OTHER TYPES OF ANCA IN ULCERATIVE-COLITIS, PRIMARY SCLEROSING CHOLANGITIS, AND CROHNS-DISEASE
PEEN E; ALMER S; BODEMAR G; RYDEN BO; SJOLIN C; TEJLE K; SKOGH T
Journal article: JOURNAL OF INTERNAL MEDICINE. 1993;233(1):93-94
CLONIDINE IN ULCERATIVE-COLITIS AND PROCTITIS
MELANDER M; ALMER S; STROM M
Journal article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 1992;27(12):1031-1038
DO TC-99M HEXAMETHYLPROPYLENE AMINE OXIME-LABELED LEUKOCYTES TRULY REFLECT THE MUCOSAL INFLAMMATION IN PATIENTS WITH ULCERATIVE-COLITIS
ALMER S; FRANZEN L; PETERS AM; TJADERMO M; EKBERG S; GRANERUS G; STROM M
Journal article: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 1992;16(6-7):564-568
RETROGRADE DISTRIBUTION OF A NEW 5-AMINOSALICYLIC ACID ENEMA IN PATIENTS WITH ULCERATIVE-COLITIS
ALMER S; EKBERG S; STROM M
Journal article: JOURNAL OF CLINICAL PHARMACOLOGY. 1992;32(1):49-54
PHARMACOKINETICS OF TRANEXAMIC ACID IN PATIENTS WITH ULCERATIVE-COLITIS AND IN HEALTHY-VOLUNTEERS AFTER THE SINGLE INSTILLATION OF 2G RECTALLY
ALMER S; ANDERSSON T; STROM M
Journal article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 1991;26(3):327-335
STEADY-STATE PHARMACOKINETICS OF A NEW 4-GRAM 5-AMINOSALICYLIC ACID RETENTION ENEMA IN PATIENTS WITH ULCERATIVE-COLITIS IN REMISSION
ALMER S; NORLANDER B; STROM M; OSTERWALD H
Journal article: DIGESTION. 1991;50(3-4):135-141
PHOSPHOLIPASE-A2 ACTIVITY OF COLONIC MUCOSA IN PATIENTS WITH ULCERATIVE-COLITIS
ALMER S; FRANZEN L; OLAISON G; SMEDH K; STROM M
Journal article: LAKARTIDNINGEN. 1990;87(16):1335-1338
[Quality of the data in a patient registry].
Almer S; Carlsson P; Fåhraeus L; Jansson I; Myrnets R
Journal article: LAKARTIDNINGEN. 1989;86(46):4002-4008
[Oral contraceptives and blood diseases are the most common causes of Budd-Chiari syndrome].
Almer S; Bodemar G; Rydén BO; Elfström J; Franzén L; Ihse I; Resjö M
Journal article: PRESSE MEDICALE. 1985;14(45):2299
CEREBRAL INFARCTION CONSECUTIVE TO A KARATE FIGHT
ALMER S; WESTERBERG CE
Journal article: LAKARTIDNINGEN. 1985;82(35):2886-2888
[Discussion of the panorama of injuries associated with karate: potential risks need new attention. Brain infarction in a 18-year-old boy after a karate blow].
Almer S; Westerberg CE
Journal article: LAKARTIDNINGEN. 1982;79(20):2033-2034
[Obscure symptoms complicate the diagnosis of brain abscess].
Almer S; Herrlin-Dallner B; Briem H; Gustavsson Moringlane IL
Show more

All other publications

Conference publication: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2024;16:I130-I131
Long-term real-world data of ustekinumab in Crohn's Disease - the Stockholm ustekinumab study - STOCUSTE
Bello F; Lordal M; Johansson F; Sabhan H; Muhsen S; Borin A; Forsberg O; Wennerstrom C; Soderman C; Almer S
Review: LAKARTIDNINGEN. 2024;121:23165
[Health-related quality of life for patients with inflammatory bowel disease requires more than anti-inflammatory treatment].
Lindgren S; Almer S; Bergemalm D; Grip O; M Hellström P; Hjortswang H; Strid H
Conference publication: JOURNAL OF CROHNS & COLITIS. 2024;18:I604
Relationship and sexuality in Inflammatory Bowel Disease: results from a patient questionnaire
Jaghult S; Bello F; Almer S
Conference publication: JOURNAL OF CROHNS & COLITIS. 2024;18:I1679-I1681
Relation between Crohn's disease phenotype and response to ustekinumab in Stockholm - the STOCUSTE study
Bello F; Muhsen S; Sabhan H; Borin A; Johansson F; Hoog C; Forsberg O; Wennerstrom C; Soderman C; Lordal M; Almer S
Conference publication: JOURNAL OF CROHNS & COLITIS. 2024;18:I2062
Early monitoring of ustekinumab concentration after induction is related to clinical remission in ulcerative colitis & Crohn`s disease - STOCUSTE study
Sabhan H; Johansson F; Bello F; Wennerstrom C; Forsberg O; Borin A; Almer S; Hoog C; Soderman C; Lordal M
Conference publication: JOURNAL OF CROHNS & COLITIS. 2023;17:I314-I315
A novel serum protein signature as biomarker for Inflammatory Bowel Disease: A diagnostic performance and prediction modelling study using data from two independent inception cohorts
Bazov I; Kruse R; Bergemalm D; Eriksson C; Hedin CR; Carlson M; van Nieuwenhoven M; Keita AV; Magnusson MK; Almer S; Strid H; Mathisen CB-W; Bengtsson MB; Aabrekk TB; Medhus AW; Detlie TE; Frigstad SO; Huppertz-Hauss G; Opheim R; Ricanek P; Kristensen VA; Salihovic S; D'Amato M; Ohman L; Soderholm JD; Lindqvist CM; Repsilber D; Hoivik ML; Halfvarson J
Conference publication: GASTROENTEROLOGY. 2023;164(6):S668-S669
A NOVEL SERUM PROTEIN SIGNATURE AS BIOMARKER FOR INFLAMMATORY BOWEL DISEASE: A DIAGNOSTIC PERFORMANCE AND PREDICTION MODELLING STUDY USING DATA FROM TWO INDEPENDENT INCEPTION COHORTS
Bazov I; Kruse R; Daniel B; Eriksson C; Hedin CR; Carlson M; van Nieuwenhoven M; Keita AV; Magnusson MK; Almer S; Strid H; Mathisen CB; Bengtson M-B; Aaabrekke TB; Medhus AW; Detlie TE; Frigstad SO; Huppertz-Hauss G; Opheim R; Ricanek P; Kristensen V; Salihovic S; D'Amato M; Ohman L; Soderholm JD; Lindqvist CM; Repsilber D; Hoivik ML; Halfvarson J
Published conference paper: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(11):1304-1311
Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
Eriksson C; Visuri I; Vigren L; Nilsson L; Karnell A; Hjortswang H; Bergemalm D; Almer S; Hertervig E; Karlen P; Strid H; Halfvarson J
Editorial comment: GASTROENTEROLOGY. 2021;160(7):2585-2587.e3
Association Between Collagenous and Lymphocytic Colitis and Risk of Severe Coronavirus Disease 2019
Khalili H; Zheng T; Soderling J; Larsson E; Munch A; Sjoberg K; Almer S; Vigren L; Janczewska I; Ohlsson B; Bresso F; Mellander M-R; Olen O; Roelstraete B; Franke A; Simon TG; D'Amato M; Ludvigsson JF
Conference publication: JOURNAL OF CROHNS & COLITIS. 2021;15:S592
Effect of vedolizumab therapy on whole blood transcriptional profiles in patients with Inflammatory Bowel Disease
Haglund S; Soderman J; Almer S
Conference publication: GASTROENTEROLOGY. 2021;160(6):S151-S152
DISCONTINUATION OF INFLIXIMAB THERAPY IN PATIENTS WITH CROHN'S DISEASE IN SUSTAINED, COMPLETE CLINICAL-BIOCHEMICAL-ENDOSCOPIC REMISSION: A DOUBLE-BLINDED, PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIAL
Buhl S; Steenholdt C; Brynskov J; Christensen KR; Dorn-Rasmussen M; Thomsen OO; Bendtzen K; Klausen TW; Dahlerup JF; Thorsgaard N; Jahnsen J; Molazahi A; Pedersen N; Kjeldsen J; Almer S; Dahl EE; Vind I; Cannon AG; Marsal J; Sipponen T; Agnholt JS; Kievit HA; Aure SL; Martinsen L; Meisner S; Moeller J; Ainsworth MA
Conference publication: JOURNAL OF CROHNS & COLITIS. 2020;14:S576-S577
Real-world effectiveness of vedolizumab in ulcerative colitis: Week 52 results from the Swedish multi-centre, prospective, observational SVEAH UC study
Eriksson C; Rundquist S; Lykiardopoulos V; Udumyan R; Karlen P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjoberg M; Oberg D; Bergemalm D; Hjortswang H; Halfvarson J
Conference publication: GASTROENTEROLOGY. 2020;158(6):S963
REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB IN CROHN'S DISEASE: WEEK 52 RESULTS FROM THE SWEDISH MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL SVEAH CD STUDY
Eriksson C; Rundquist S; Lykiardopoulos B; Udumyan R; Karlen P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjoberg M; Oberg D; Daniel B; Hjortswang H; Halfvarson J
Conference publication: JOURNAL OF CROHNS & COLITIS. 2019;13:S510-S511
Medical treatment and surgery in patients with elderly-onset inflammatory bowel disease: 3-year follow-up of Epi-IBD 2010-2011 cohorts
Hernandez V; Martinez-Cadilla J; Langholz E; Christodoulou D; Turcan S; Valpiani D; Lakatos PL; Vegh Z; Goldis A; Belousova E; Ladefoged K; Kiudelis G; McNamara D; Shonova O; Krznaric Z; Magro F; Bjornsson ES; Almer S; Fumery M; Duricova D; Kievit A; Kaimakliotis I; Ellul P; Niewiadomski O; Giannotta M; Odes S; Pedersen N; Dahlerup JF; Salupere R; D'Inca R; Halfvarson J; Oksanen P; Arebi N; Nielsen KR; Andersen V; Shaji S; Munkholm P; Burisch J
Conference publication: JOURNAL OF IMMUNOLOGY. 2019;202(1)
Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation
Mazzurana L; Forkel M; Rao A; Van Acker A; Kokkinou E; Ichiya T; Almer S; Hoog C; Friberg D; Mjosberg J
Conference publication: JOURNAL OF IMMUNOLOGY. 2019;202(1)
Heterogeneity in differentiation capacity among ILC precursors in human peripheral blood and tissues
Kokkinou E; Gutierrez-Perez I; Pandey RV; Rao A; Mazzurana L; Almer S; Hoog C; Lindforss U; Bryceson Y; Mjosberg J
Conference publication: JOURNAL OF CROHNS & COLITIS. 2018;12:S494-S495
Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn's disease (SVEAH CD)
Eriksson C; Rundquist S; Lykiardopoulos V; Karlen P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjoberg M; Oberg D; Bergemalm D; Udumyan R; Hjortswang H; Halfvarson J
Conference publication: JOURNAL OF CROHNS & COLITIS. 2018;12:S382-S383
Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)
Eriksson C; Rundquist S; Lykiardopoulos V; Karlen P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjoberg M; Oberg D; Bergemalm D; Udumyan R; Hjortswang H; Halfvarson J
Conference publication: JOURNAL OF CROHNS & COLITIS. 2018;12:S409-S410
Clinical effectiveness of golimumab: Interim analysis of the observational study of patients with ulcerative colitis on golimumab in the Swedish National Quality Registry for IBD-GO-SWIBREG
Eriksson C; Bergemalm D; Vigren L; Nilsson L; Visuri I; Hjortswang H; Udumyan R; Almer S; Seddighzadeh M; Hertervig E; Karlen P; Strid H; Halfvarson J
Conference publication: GASTROENTEROLOGY. 2018;154(6):S841
CLINICAL EFFECTIVENESS OF VEDOLIZUMAB: INTERIM ANALYSIS OF THE SWEDISH OBSERVATIONAL STUDY ON VEDOLIZUMAB ASSESSING EFFECTIVENESS AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH CROHN'S DISEASE (SVEAH CD)
Eriksson C; Rundquist S; Lykiardopoulos V; Karlen P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjoberg M; Oberg D; Bergemalm D; Udumyan R; Hjortswang H; Halfvarson J
Conference publication: GASTROENTEROLOGY. 2018;154(6):S842
CLINICAL EFFECTIVENESS OF VEDOLIZUMAB: INTERIM ANALYSIS OF THE SWEDISH OBSERVATIONAL STUDY ON VEDOLIZUMAB ASSESSING EFFECTIVENESS AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH ULCERATIVE COLITIS (SVEAH UC)
Eriksson C; Rundquist S; Lykiardopoulos V; Karlen P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Malmgren C; Delin J; Strid H; Sjoberg M; Oberg D; Bergemalm D; Udumyan R; Hjortswang H; Halfvarson J
Conference publication: HEPATOLOGY. 2018;68:1079A-1080A
Impact of Geographical Region on Death or Transplantation and on Malignancy in Primary Sclerosing Cholangitis - a Multicenter Retrospective Study of the International PSC Study Group (IPSCSG)
Weismueller TJ; Gulamhusein A; Trivedi P; Bergquist A; Juran BD; Ponsioen CY; Tanaka A; Rupp C; Farkkila M; Villamil AG; Marschall H-U; Thorbum D; Lenzen H; Folseraas T; Weersma RK; Fevery J; Mueller T; Chazouilleres O; Almer S; Pereira SP; Levy C; Zigmond E; Ma X; Mason A; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Taneja S; Dalekos GN; Eksteen B; Invernizzi P; Berg C; Kirchner GI; Lazaridis KN; Trauner MH; Strassburg CP; Hirschfield G; Schramm C; Manns MP; Hansen BE; Boberg KM
Conference publication: JOURNAL OF CROHNS & COLITIS. 2017;11:S262-S263
A Swedish observational study (SVEAH) on vedolizumab assessing effectiveness and healthcare resource utilization in patients with inflammatory bowel disease
Eriksson C; Rundquist S; Lykiardopoulos B; Karlen P; Grip O; Soderman C; Almer S; Hertervig E; Gunnarsson J; Delin J; Strid H; Sjoberg M; Oberg D; Hjortswang H; Halfvarson J
Corrigendum: NATURE COMMUNICATIONS. 2016;7:12936
Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth (vol 7, 12321, 2016)
Gerling M; Buller NVJA; Kirn LM; Joost S; Frings O; Englert B; Bergstrom A; Kuiper RV; Blaas L; Wielenga MCB; Almer S; Kuhl AA; Fredlund E; van den Brink GR; Toftgard R
Conference publication: JOURNAL OF CROHNS & COLITIS. 2016;10:S310
Efficacy of vedolizumab in patients with inflammatory bowel disease and failure of anti-TNF-antibodies
Hoog C; Eberhardson M; Almer S
Conference publication: JOURNAL OF CROHNS & COLITIS. 2016;10:S453-S454
Frequency of anaemia and anaemia subtypes in east-west European inception cohort: an ECCO-EpiCom cohort study
Burisch J; Gerdes U; Almer S; Cukovic-Cavka S; Sebastian S; Kaimakliotis I; Duricova D; Pedersen N; Salupere R; Nielsen KR; Manninen P; Katsanos KH; Odes S; Andersen V; D'Inca R; Kupcinskas L; Turcan S; Magro F; Goldis A; Vinding KK; Belousova E; Ladefoged K; Bailey Y; Hernandez V; Halfvarson J; Arebi N; Shonova O; Hoivik ML; Moum B; Langholz E; Lakatos PL; Munkholm P; Dahlerup JF
Review: LAKARTIDNINGEN. 2015;112:DF7L
[The usefulness of pharmacogenetics for a more individualized treatment. The example thiopurines in inflammatory bowel disease and childhood leukemia].
Lindqvist Appell M; Mårtensson L-G; Almer S; Peterson C
Conference publication: JOURNAL OF CROHNS & COLITIS. 2015;9:S251
Rapid weight increase in Infliximab treated Crohn's disease patients is sustained over time
Lepp J; Forsell A; Fyrhake U; Lordal M; Almer S
Conference publication: HEPATOLOGY. 2015;62:246A-247A
Gender and IBD phenotype are independent predictors of death or transplantation and of malignancy in Primary Sclerosing Cholangitis - a multicenter retrospective study of the International PSC Study Group (IPSCSG)
Weismuller TJ; Hansen BE; Trivedi PJ; Imam M; Lenzen H; Ponsioen CY; Holm K; Beuers U; Bergquist A; Gotthardt D; Marschall H-U; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouilleres O; Schramm C; Lazaridis K; Juran BD; Farkkila MA; Pereira SP; Almer S; Levy C; Mason A; Bowlus CL; Floreani A; Halilbasic E; Trauner M; Yimam KK; Milkiewicz P; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Invernizzi P; Braun F; Marzioni M; Berg CP; Lohse AW; Hirschfield G; Strassburg CP; Manns MP; Lindor KD; Karlsen TH; Boberg KM
Conference publication: GASTROENTEROLOGY. 2015;148(4):S871
Vedolizumab in Inflammatory Bowel Disease, the First Experience From the Swedish IBD Registry (SWIBREG)
Eriksson C; Almer S; Bjoerk JA; Eberhardson M; Eriksson A; Grip O; Hertervig E; Hoeoeg C; Jaeghult S; Karlen P; Ludvigsson J; Marsal J; Sjoeberg D; Stjernman H; Strid H; Thoern M; Vigren L; Hjortswang H; Halfvarson J
Meeting abstract: JOURNAL OF HEPATOLOGY. 2014;60(1):S3
PRIMARY SCLEROSING CHOLANGITIS FROM A GLOBAL PERSPECTIVE - A MULTICENTER, RETROSPECTIVE, OBSERVATIONAL STUDY OF THE INTERNATIONAL PSC STUDY GROUP
Weismueller TJ; Talwalkar JA; Ponsioen CY; Gotthardt DN; Marschall H-U; Naess S; Holm K; Weersma RK; Lazaridis KN; Fevery J; Trivedi PJ; Schramm C; Chazouilleres O; Mueller T; Farkkila M; Almer S; Pereira S; Mason AL; Floreani A; Milkiewicz P; Harley H; Pares A; de Vries L; Manser C; Gatselis N; Berg C; Lenzen H; de Valle MB; Imam M; Kirchner G; de Leuw P; Zimmer V; Fabris L; Braun F; Hirschfield GM; Marzioni M; Juran BD; Strassburg CP; Beuers U; Manns MP; Schrumpf E; Karlsen TH; Bergquist A; Boberg KM
Meeting abstract: JOURNAL OF CROHNS & COLITIS. 2014;8:S345
Effects of allopurinol on thiopurine metabolism and gene expression levels in HepG2 cells
Haglund S; Zimdahl A; Vikingsson S; Almer S; Soderman J
Meeting abstract: JOURNAL OF CROHNS & COLITIS. 2014;8:S307
A combination of low-dose thiopurine and allopurinol (ThioComp) is long-term efficacious and well-tolerated in IBD patients
Almer S; Wagner A; Mahl M; Hindorf U
Meeting abstract: JOURNAL OF CROHNS & COLITIS. 2014;8:S347-S348
Association between genetic markers related to tight junctions and inflammatory bowel disease
Noren E; Almer S; Soderman J
Meeting abstract: JOURNAL OF CROHNS & COLITIS. 2014;8:S5-S6
The cost of investigations and medical treatment including biological therapy in a European inception cohort from the biological era - An ECCO-EpiCom study
Burisch J; Kaimakliotis I; Duricova D; Thorsgaard N; Andersen V; Nielsen KR; Tsianos EV; Ladefoged K; Bailey Y; D'Inca R; Kupcinskas L; Turcan S; Magro F; Goldis A; Belousova E; Hernandez V; Almer S; Halfvarson J; Sebastian S; Langholz E; Odes S; Munkholm P
Conference publication: GASTROENTEROLOGY. 2014;146(5):S203
The Cost of Medical Management, Surgery and Clinical Investigations in a European Population-Based Inception Cohort From the Biological Era - An ECCO-Epicom Study
Burisch J; Pedersen N; Cukovic-Cavka S; Kaimakliotis J; Duricova D; Shonova O; Vind I; Thorsgaard N; Andersen V; Dahlerup JF; Salupere R; Nielsen KR; Manninen P; Tsianos EV; Ladefoged K; Bailey Y; D'Inca R; Kupcinskas L; Turcan S; Magro F; Goldis A; Belousova E; Hernandez V; Almer S; Halfvarson J; Sebastian S; Lakatos PL; Langholz E; Odes SH; Munkholm P
Conference publication: JOURNAL OF HEPATOLOGY. 2013;58:S382-S383
RISK FOR HEPATOCELLULAR CARCINOMA IN AUTOIMMUNE HEPATITIS - IS THERE AN INDICATION FOR SURVEILLANCE?
Borssen AD; Lindgren S; Bergquist A; Almer S; Sangfelt P; Werner M
Letter: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2013;37(1):162-163
Letter: successful mercaptopurine therapy after azathioprine-related pancreatitis in patients with IBD Reply
Hindorf U; Almer S
Conference publication: HEPATOLOGY. 2013;58:883A
Hypercoagulability in portal vein thrombosis is related to the presence of liver cirrhosis
Rajani R; Chaireti R; Bergquist A; Melin T; Friis-Liby I; Kapraali M; Kechagias S; Lindahl TL; Almer S
Conference publication: GASTROENTEROLOGY. 2012;142(5):S569-S570
Is There an East-West Gradient in the Incidence of IBD in Europe? and Further Far East in China? First Results From the Epicom Study
Burisch J; Xia B; Cukovic-Cavka S; Kaimakliotis J; Duricova D; Shonova O; Vind I; Pedersen N; Langholz E; Thorsgaard N; Andersen V; Dahlerup JF; Salupere R; Nielsen KR; Manninen P; Tsianos EV; Ladefoged K; Bjornsson E; Bailey Y; Odes SH; Martinato M; Kupcinskas L; Turcan SI; Magro F; Goldis A; Belousova E; Hernandez V; Almer S; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Munkholm PS
Conference publication: EUROPEAN JOURNAL OF CANCER. 2011;47:S650
Rapid Method to Measure Thioguanine Incorporation Into DNA
Vikingsson S; Carlsson B; Coulthard S; Josefsson M; Almer S; Peterson C
Letter: INFLAMMATORY BOWEL DISEASES. 2011;17(4):1055
RIP2 Polymorphisms in Inflammatory Bowel Diseases
Theibaut R; Douchin V; Jung C; Merlin F; Colombel JF; Lemann M; Almer S; Tysk C; O'Morain C; Gassull M; Finkel Y; Zouali H; Pascoe L; Hugot JP
Conference publication: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2011;127(2):AB185
Oral Food Challenges in 1 Year Old Infants Using Pre-Determined Challenge Criteria
Allen KJ; Koplin JJ; Almer S; Dawson D; Dang T; Dharmage S; Gurrin L; Hill D; Lowe A; Matheson M; Martin P; Miles L; Osborne N; Ponsonby A; Robertson M; Slaa M; Sutherland M; Tan T; Tang M; Tey D; Thiele L; Wake M
Conference publication: GASTROENTEROLOGY. 2011;140(5):S590
Infliximab as Rescue Therapy in Steroid-Refractory Acute Ulcerative Colitis; A Retrospective Follow-up Study
Sjoberg M; Almer S; Befrits R; Benoni C; Carlson M; Eriksson A; Friis-Liby I; Halfvarson J; Hertervig E; Karlen P; Lapidus AB; Magnuson A; Midhagen G; Tysk C
Published conference paper: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS. 2010;29(4-6):278-283
How Should Thiopurine Treatment be Monitored? Methodological Aspects
Vikingsson S; Carlsson B; Almer S; Peterson C
Published conference paper: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS. 2010;29(4-6):267-277
Novel Strategies in the Thiopurine Treatment of Inflammatory Bowel Disease
Almer S
Conference publication: HEPATOLOGY. 2010;52(4):912A
INCREASED FACTOR VIII ACTIVITY IN PORTAL VEIN THROMBOSIS AND BUDD-CHIARI SYNDROME
Rajani R; Bergquist A; Melin T; Friis-Liby I; Kapraali M; Werner M; Sangfelt P; Wallerstedt S; Lindahl TL; Almer S
Review: LAKARTIDNINGEN. 2009;106(45):2994-2998
[Management of severe attack of ulcerative colitis].
Tysk C; Almer S; Andersson MV; Befrits R; Hertervig E; Kilander A; Lindgren S; Suhr O
Review: LAKARTIDNINGEN. 2009;106(45):2988-2993
[Current drug therapy in Crohn disease--national guidelines].
Almer S; Befrits R; Eriksson AS; Halfvarson J; Hindorf U; Löfberg R
Letter: GUT. 2009;58(6):889
Incidence and prevalence rates in Budd-Chiari syndrome
Rajani R; Almer S
Meeting abstract: JOURNAL OF HEPATOLOGY. 2009;50:S303
HEPATIC AND EXTRAHEPATIC MALIGNANCIES INAUTOIMMUNE HEPATITIS
Werner M; Almer S; Prytz H; Lindgren S; Danielsson A
Meeting abstract: JOURNAL OF HEPATOLOGY. 2009;50:S242
HIGH PLASMA RESISTIN LEVELS IN AUTOIMMUNE HEPATITIS
Bostrom EA; Bokarewa M; Almer SH
Conference publication: GASTROENTEROLOGY. 2009;136(5):A854
The Prevalence of Elevated IgG4 Levels in Patients with Primary Sclerosing Cholangitis
Bjornsson E; Almer SH; Prytz H; Werner M; Sangfelt P; Rajani R
Conference publication: GASTROENTEROLOGY. 2009;136(5):A678
A "Skewed" Thiopurine Metabolite Profile in IBD Patients Is Not Explained By Variations in Inosine-5-Monophosphate Dehydrogenase Activity
Haglund S; Vikingsson S; Taipalensuu J; Coulthard S; Hindorf U; Danelius M; Peterson C; Almer SH
Conference publication: GASTROENTEROLOGY. 2009;136(5):A209
Genetic Association Between Crohn's Disease and a Marker Located in the Region of Claudin 2 Implicates the Intestinal Barrier As a Primary Risk Factor in a Swedish Population
Slanemyr E; Taipalensuu J; Christiansson M; Andreasson H; Thiebaut R; Hugot J-P; Tysk C; O'Morain CA; Gassull M; Finkel Y; Colombel J-F; Lemann M; Almer SH
Meeting abstract: JOURNAL OF HEPATOLOGY. 2008;48:S331-S332
Epidemiology and the initial presentation of autoimmune hepatitis type 1 in Sweden, a nationwide study
Werner M; Prytz H; Ohlsson B; Almer S; Bjornsson E; Bergquist A; Wallerstedt S; Sandberg-Gertzen H; Hultcrantz R; Sangfelt P; Weiland O; Danielsson A
Conference publication: GASTROENTEROLOGY. 2007;132(4):A185
6-thioguanine therapy in Crohn's disease - A Swedish experience
Almer SH; Hjortswang H; Peterson C; Hindorf U
Conference publication: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2007;42:15
Autoimmune hepatitis in Sweden.
Werner M; Bjornsson E; Prytz H; Ohlsson B; Almer S; Bergquist A; Waller-stedt S; Sandberg-Gertzen H; Hultcrantz R; Sangfeldt P; Nilsson J; Danielsson A
Conference publication: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2006;41:32
Portal vein thrombosis:: Clinical presentation, risk factors and outcome in a large Swedish patient cohort
Rajani R; Almer S; Bjornsson E; Danielsson A; Broome U; Gustavsson A; Grip O; Melin T; Sangfelt P; Wallerstedt S
Conference publication: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2006;41:34
Etiological factors and survival in 45 Swedish patients with the Budd-Chiari syndrome
Rajani R; Almer S; Broom U; Melin T; Bjornsson E; Sangfelt P; Danielsson A; Gustavssonl A; Grip O; Wallerstedt'O S; Svensson H
Conference publication: GASTROENTEROLOGY. 2006;130(4):A619
Adverse events leading to modification of therapy in a large cohort of azathioprine-treated patients with inflammatory bowel disease
Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
Published conference paper: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS. 2006;25(9-11):1033-1037
No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease
Lindqvist M; Hindorf U; Almer S; Soderkvist P; Strom M; Hjortswang H; Peterson C
Conference publication: HEPATOLOGY. 2005;42(4):466A-467A
Detection of cholangiocarcinoma (CC) using positron emission tomography (PET) in patients accepted for liver transplantation (TX) for primary sclerosing cholangitis (PSC).: A prospective Swedish-Danish study.
Prytz H; Keiding S; Björnsson E; Almer S; Castedal M
Conference publication: GASTROENTEROLOGY. 2005;128(4):A308
Lack of association between the inosine triphosphate pyrophosphatase (ITPA) 94C>A polymorphism, the TPMT genotype, the baseline tpmt activity and adverse effects from thiopurine medication in inflammatory bowel disease
Hindorf U; Lindqvist M; Ström M; Hjortswang H; Peterson C; Almer S
Conference publication: GASTROENTEROLOGY. 2005;128(4):A303
An early postoperative leukocyte scan predicts endoscopic recurrence of Crohn's disease
Almer S; Granerus G; Lemann M; Huglo D; Andersson P; Cocq P; Colombel JF; Steinling M; Rain JD; Modigliani R
Letter: BRITISH JOURNAL OF SURGERY. 2004;91(10):1381
Perianal Crohn's disease (Br J Surg 2004;91:801-814)
Olaison G; Almer S; Anderson P
Corrigendum: CLINICAL CHEMISTRY. 2004;50(4):788
Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease (vol 50, pg 288, 2004)
Haglund S; Lindqvist M; Almer S; Peterson C; Taipalensuu J
Conference publication: GASTROENTEROLOGY. 2004;126(4):A212
Thiopurine methyltransferase and the metabolism of thiopurine drugs in a large Swedish population
Hindorf U; Almer S; Peterson C
Conference publication: CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 2004;31(11):A219
Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity
Lindqvist M; Almer S; Haglund S; Peterson C; Soderkvist P; Taipalensuu J
Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2002;10:82-83
Haplotypic and cladistic analyses revealed a marked dispersion of CD-predisposing nucleotide variations in CARD15/NOD2
Chamaillard M; Zouali H; Lesage S; Cézard J; Belaiche J; Almer S; Tysk C; Montague S; Gassull M; Binder V; Finkel Y; Puig P; Gower-Rousseau C; Macry J; Colombel J; Sahbatou M; Thomas G; Hugot J
Conference publication: GASTROENTEROLOGY. 2002;122(4):A29
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease
Hugot JP; Lesage S; Zouali H; Cezard JP; Colombel JF; Belaiche J; Almer S; Tysk C; O'Morain C; Gassull MA; Binder V; Finkel Y; Modigliani R; Gower-Rousseau C; Merlin F; Chamaillard M; Thomas G
Conference publication: AMERICAN JOURNAL OF HUMAN GENETICS. 2002;71(4):490
CARD4/NOD1 in inflammatory bowel disease.
Zouali H; Lesage S; Merlin F; Cézard J; Colombel J; Belaiche J; Almer S; Tysk C; O'Morain C; Gassull M; Modigliani R; Gower-Rousseau C; Chamaillard M; Thomas G; Hugot JP
Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2002;10:82
CARD15 mutations in families with "mixed" inflammatory bowel disease
Lesage S; Zouali H; Merlin F; Chamaillard M; Cézard J; Belaiche J; Almer S; Tysk C; O'Morain C; Gassull M; Binder V; Modigliani R; Gower-Rousseau C; Colombel J; Thomas G; Hugot J
Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2002;10:82
Mutational analysis of CARD4/NOD1 gene and inflammatory bowel disease
Zouali H; Lesage S; Merlin F; Chamaillard M; Cézard J; Belaiche J; Almer S; Tysk C; O'Morain C; Gassull M; Binder V; Finkel Y; Modigliani R; Gower-Rousseau C; Colombel J; Thomas G; Hugot J
Conference publication: AMERICAN JOURNAL OF HUMAN GENETICS. 2001;69(4):642
Mutational analysis and phenotype-genotype correlation of the NOD2 gene in Crohn disease.
Lesage S; Zouali H; Czard JP; Belaiche J; Almer S; Tysk C; O'Morain CA; Gassul M; Modigliani R; Colombel JF; Merlin F; Chamaillard M; Thomas G; Hugot JP
Conference publication: AMERICAN JOURNAL OF HUMAN GENETICS. 2001;69(4):410
Distribution of Crohn's disease susceptibility haplotypes in European families.
Zouali H; Lesage S; Chamaillard M; Czard JP; Belaiche J; Almer S; Tysk C; O'Morain C; Gassul M; Modigliani R; Colombel JF; Sahbatou M; Thomas G; Hugot JP
Letter: LANCET. 2000;356(9224):163-164
Mycophenolate mofetil in Crohn's disease
Rampton DS; Neurath MF; Almer S; D'Haens G; Petritsch W; Stange EF
Conference publication: GASTROENTEROLOGY. 2000;118(4):A333
Protective effect of CCR5 Δ32 base pair deletion in Crohn's disease.
Zouali H; Chamaillard M; Colombel JF; Belaiche J; Côzard JP; Tysk C; Almer S; Gassull MA; Binder V; Lesage S; Thomas G; Hugot JP
Conference publication: GASTROENTEROLOGY. 2000;118(4):A332-A333
Protective effect of CYP2D6*4 allele in ulcerative colitis disease.
Lesage S; Chamaillard M; Colombel JF; Belaiche J; Cizard JP; Tysk C; Almer S; Gassull MA; Binder V; Zouali H; Thomas G; Hugot JP
Conference publication: GASTROENTEROLOGY. 1999;116(4):A740
Mutation screening in the CD19 and CD43 (sialophorin) genes in Crohn disease patients
Hugot JP; Zouali H; Colombel JF; Belaiche J; Cezard JP; Gassull M; Tysk C; Almer S; Binder V; Van Gossum A; Lofberg R; Parrello T
Conference publication: GASTROENTEROLOGY. 1999;116(4):A740
Linkage analysis of chromosome 12 loci in Crohn's disease families.
Lesage S; Hugot JP; Colombel JF; Belaiche J; Cezard JP; Gassull M; Tysk C; Almer S; Binder V; Van Gossum A; Lofberg R; Parrello T
Conference publication: AMERICAN JOURNAL OF HUMAN GENETICS. 1999;65(4):A473
Protective effect of CCR5 32 base pairs deletion in Crohn's Disease.
Zouali H; Chamaillard M; Colombel J; Belaiche J; Cezard JP; Tysk C; Almer S; Gasull M; Binder V; Lesage S; Macry J; Thomas G; Hugot JP
Review: LAKARTIDNINGEN. 1998;95(35):3666-3668
[New knowledge of heredity in inflammatory bowel disease. Specific gene mapping in a EU-project].
Almer S; Tysk C; Löfberg R
Review: LAKARTIDNINGEN. 1998;95(9):860-866
[Leukocyte scintigraphy, endoscopy, airway x-ray. New methods for the diagnosis of colitis and Crohn disease].
Almer S; Smedh K
Conference publication: GASTROENTEROLOGY. 1997;112(4):A921
Leukocyte scanning validated with whole small bowel endoscopy in Crohn's disease patients and controls
Almer S; Granerus G; Strom M; Olaison G; Lemann M; Bonnet J; Franzen L; Bertheau P; Rain JD; Cattan P; Modigliani R
Other: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 1995;22(9):1039-1041
UP-REGULATION OF GRANULOCYTE CD11B (CR-3) AFTER LABELING WITH TC-99M HEXAMETHYLPROPYLENE AMINE OXIME
ALMER S; LJUNGHUSEN O
Show more

Grants

Evaluating Resective and Transplantation Liver Surgery by Liver Intrinsic Function Evaluation (LIFE)
Swedish Research Council
1 January 2013 - 31 December 2015
Translational studies of thiopurines for individualized treatment of inflammatory bowel disease with focus on the pharmacogenetics.
Swedish Research Council
1 January 2009 - 31 December 2011

Articles

All other publications

Grants

News from KI

Events from KI